from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1385/pyrF

LFCtreatmentdescriptionclass of inhibitor

-0.573

Amikacinug/mL Amikacintranslation

-1.278

Cap5-10ug/mL Capreomycintranslation

-1.089

Rox10-50 ug/mL Roxithromycintranslation

0.099

SM2-5 ug/mL Streptomycintranslation

-1.368

Tet5-10 ug/mL Tetracyclinetranslation

0.360

Rif0.2-5ug/mL Rifampicintranscription

-0.025

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.183

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.183

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.687

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.315

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.288

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.899

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.051

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.514

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.778

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.120

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.026

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.167

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.263

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.641

KCN5-20 ug/mL Potassium cyaniderespiration

-0.323

NaN30.2-2 mM Sodium aziderespiration

-0.511

Nigericin50 uM Nigericinrespiration

0.958

TRC10-150 ug/mL Triclosanrespiration

-0.946

TRZ10-25 ug/mL Thioridazinerespiration

-1.537

Valinomycin0.5-10 uM Valinomycinrespiration

-0.966

ZnSO42 mM ZnSO4respiration

0.699

menadione6-10 ug/mL Menadionerespiration

-0.436

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.049

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.249

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.336

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.171

NRP_1Non-replicating persistence stage 1dosRassociated

0.252

Amp0.2mg/mL AmpicillincellWall

0.220

Cephalexin20-100 ug/mL CephalexincellWall

-0.264

Cerulenin0.32-5 ug/mL CerulenincellWall

0.625

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.257

EMB10-20 ug/mL EthambutolcellWall

-0.349

Eta12-40 ug/mL EthionamidecellWall

-0.066

INH0.2-0.4 ug/mL IsoniazidcellWall

0.094

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.179

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.237

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.117

BZA0.12 mg/mL BenzamidearomaticAmides

0.372

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.266

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.573

H2O24 mM hydrogen peroxideDNAdamaging

-0.419

Levo10 ug/mL LevofloxacinDNAdamaging

-0.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.864

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.264

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.071

UVUV-irradiationDNAdamaging

-1.279

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.169

Antimycin12.5-50 ug/mL Antimycin A?

-0.589

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.242

PA_110-50 ug/mL Antitubercular compound PA-1?

0.422

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.461

PA8240.2-2 ug/mL PA-824?

0.062

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.275

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.085

Verapamil50 uM Verapamil?

-0.277

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.897

methoxatin10-20 ug/mL Methoxatin?